![Graeme Fielder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graeme Fielder is currently the Chief Operating Officer at AviadoBio Ltd. He previously worked as the Head of Corporate Development at Astellas Gene Therapies, Inc. Dr. Fielder holds an MBA from Stanford University and has undergraduate and doctorate degrees from Auckland University.
| Sociétés | Poste | Début |
|---|---|---|
AviadoBio Ltd.
 AviadoBio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for frontotemporal dementia and amyotrophic lateral sclerosis | Directeur des opérations | 04/10/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auckland University
 Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
AviadoBio Ltd.
AviadoBio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for frontotemporal dementia and amyotrophic lateral sclerosis | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
